Newborn Screening Protocols and Positive Predictive Value for Congenital Adrenal Hyperplasia Vary across the United States

• Autores principales: Phyllis W. Speiser (Autor), Reeti Chawla (Autor), Ming Chen (Autor), Alicia Diaz-Thomas (Autor), Courtney Finlayson (Autor), Meilan M. Rutter (Autor), David E. Sandberg (Autor), Kim Shimy (Autor), Rashida Talib (Autor), Jane Cerise (Autor), Eric Vilain (Autor), Emmanuèle C. Délot (Autor)
• Formato: Libro
• Publicado: MDPI AG, 2020-05-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Newborn screening for congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency is mandated throughout the US. Filter paper blood specimens are assayed for 17-hydroxyprogesterone (17OHP). Prematurity, low birth weight, or critical illness cause falsely elevated results. The purpose of...